Jabil Healthcare Market Research Report

Background

Overview

Jabil Healthcare, a division of Jabil Inc., is a leading provider of comprehensive design, engineering, and manufacturing solutions for the healthcare industry. Established in 1966 and headquartered in St. Petersburg, Florida, Jabil has expanded its global footprint to over 100 sites across 30 countries, employing more than 140,000 individuals. The consolidation of Jabil's healthcare operations under the Jabil Healthcare brand in 2020 unified its medical device, orthopedics, diagnostics, pharmaceutical delivery systems, and consumer health sectors, positioning it as the largest healthcare manufacturing solutions provider worldwide.

Mission and Vision

Jabil Healthcare's mission is to deliver innovative, high-quality manufacturing solutions that enhance patient outcomes and advance healthcare technologies. Its vision is to be the most technologically advanced and trusted manufacturing solutions provider in the healthcare sector, driving value through operational excellence and customer-centric approaches.

Primary Area of Focus

The division focuses on five key sectors within the healthcare market:

• Medical Devices: Manufacturing of devices such as minimally invasive devices, robotic-assisted surgery instruments, complex catheters, and diabetes care products.

• Orthopedics: Production of orthopedic implants and surgical instruments for spine, trauma, and craniomaxillofacial markets.

• Diagnostics: Development of diagnostic imaging equipment, instruments, and consumables for central labs, molecular point-of-care, and genomics.

• Pharmaceutical Delivery Systems: Design and manufacturing of drug delivery devices, including autoinjectors, pen injectors, inhalers, and on-body pumps.

• Consumer Health: Creation of health and wellness products aimed at improving daily living and independence.

Industry Significance

Jabil Healthcare's extensive capabilities and global presence make it a pivotal player in the healthcare manufacturing industry, offering end-to-end solutions that accelerate product development and market entry for leading healthcare brands. Its expertise in integrating components and subsystems into complex medical devices and systems underscores its critical role in advancing healthcare technologies.

Key Strategic Focus

Core Objectives

• Innovation Acceleration: Leveraging advanced manufacturing technologies to expedite product development cycles.

• Operational Excellence: Ensuring high-quality standards and regulatory compliance across all manufacturing processes.

• Customer-Centric Solutions: Providing tailored manufacturing services that meet the unique needs of each client.

Specific Areas of Specialization

• Advanced Manufacturing Technologies: Utilization of additive manufacturing, automation, and sensor integration to enhance product functionality and efficiency.

• Regulatory Compliance: Adherence to stringent industry standards, including ISO 13485, FDA regulations, and MedAccred® accreditations.

• Supply Chain Management: Expertise in global supply chain orchestration, ensuring timely and cost-effective delivery of products.

Key Technologies Utilized

• Additive Manufacturing: Enabling rapid prototyping and complex component production.

• Automation and Robotics: Streamlining manufacturing processes to improve precision and reduce cycle times.

• Sensor Integration: Incorporating sensors into devices for enhanced functionality and data collection.

Primary Markets Targeted

• Medical Device Manufacturers: Companies seeking reliable and innovative manufacturing partners for complex medical devices.

• Pharmaceutical Companies: Organizations requiring efficient and compliant production of drug delivery systems.

• Diagnostic Equipment Providers: Firms needing advanced manufacturing solutions for diagnostic instruments and consumables.

Financials and Funding

Funding History

As a division of Jabil Inc., Jabil Healthcare's financials are integrated into the parent company's overall performance. Jabil Inc. reported a revenue of $34.7 billion in the fiscal year ending August 31, 2023.

Recent Funding Rounds

Specific details regarding recent funding rounds for Jabil Healthcare are not publicly disclosed.

Notable Investors

As a subsidiary of Jabil Inc., Jabil Healthcare's investors include institutional shareholders and stakeholders in Jabil Inc.

Intended Utilization of Capital

Capital investments are directed towards expanding manufacturing capabilities, enhancing technological infrastructure, and supporting research and development initiatives to drive innovation in healthcare manufacturing solutions.

Pipeline Development

Key Pipeline Candidates

Jabil Healthcare is involved in the development and manufacturing of various medical devices, orthopedic implants, diagnostic instruments, and pharmaceutical delivery systems. Specific details about individual pipeline candidates are proprietary and not publicly disclosed.

Stages of Clinical Trials or Product Development

Jabil Healthcare's role primarily focuses on the manufacturing aspect of product development, collaborating with clients to bring their products from design to market readiness.

Target Conditions

The company's products address a wide range of medical conditions, including orthopedic injuries, chronic diseases, diagnostic needs, and pharmaceutical delivery requirements.

Relevant Timelines for Anticipated Milestones

Timelines for product development and market introduction vary depending on the specific project and client requirements.

Technological Platform and Innovation

Proprietary Technologies

• Jabil InControl™: An award-winning supply chain decision support platform that provides end-to-end visibility and analytics.

• Additive Manufacturing Capabilities: Advanced 3D printing technologies for rapid prototyping and complex component production.

Significant Scientific Methods

• Design for Manufacturability (DFM): Ensuring product designs are optimized for efficient and cost-effective manufacturing.

• Value Engineering: Analyzing product designs to identify cost-saving opportunities without compromising quality.

AI-Driven Capabilities

• Predictive Analytics: Utilizing AI to forecast supply chain needs and optimize inventory management.

• Process Automation: Implementing AI and machine learning to enhance manufacturing efficiency and precision.

Leadership Team

Key Executive Profiles

• Steve Borges: CEO and Executive Vice President of Jabil Healthcare, leading the division's strategic direction and operations. He brings extensive experience in healthcare manufacturing and has been instrumental in consolidating Jabil's healthcare operations. Borges has also led the integration of Nypro into Jabil Healthcare, enhancing the division's capabilities and market position.

• Mike Dastoor: CEO of Jabil Inc., overseeing the overall operations and strategic initiatives of the parent company. With a background in engineering, he has held various leadership roles within Jabil, contributing to its growth and diversification. Dastoor has guided Jabil through significant acquisitions and expansions, including the acquisition of Pharmaceutics International, Inc. (Pii) in 2025.

• Gregory Hebard: CFO of Jabil Inc., responsible for the financial strategy and management of the company. With a strong financial background, he has been pivotal in managing Jabil's financial operations and strategic investments supporting growth initiatives and operational efficiency.

Leadership Changes

Recent Significant Changes or Appointments

• Mark Mondello: Executive Chairman of the Board, announced to leave the company in January 2026.

Competitor Profile

Market Insights and Dynamics

The healthcare manufacturing industry is characterized by rapid technological advancements, stringent regulatory requirements, and a growing demand for innovative medical solutions. Companies are increasingly focusing on digital health, additive manufacturing, and global supply chain optimization to meet market needs.

Competitor Analysis

• Flex Ltd.: A global leader in contract manufacturing, offering a broad range of services across various industries.

• Sanmina Corporation: Specializes in integrated manufacturing solutions, including medical device manufacturing.

• Celestica Inc.: Provides end-to-end product lifecycle solutions, with a focus on healthcare and life sciences.

Strategic Collaborations and Partnerships

Jabil Healthcare has established strategic collaborations with various healthcare companies to enhance product development and manufacturing capabilities. Notably, it has worked with Elvie, a women's technology company, to bring innovative health products to market.

Operational Insights

Jabil Healthcare's extensive global network, advanced manufacturing technologies, and commitment to quality and regulatory compliance provide it with a competitive edge in the healthcare manufacturing sector. Its ability to offer end-to-end solutions and adapt to evolving market demands remains central to its position in the industry.